Qube Research & Technologies (QRT)’s CVS Health CVS Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$11M	Sell	153,100 -303,100	-66%	-$23.3M	0.01%	1222
2025 Q4	$36.2M	Buy	456,200 +103,800	+29%	+$8.18M	0.04%	635
2025 Q3	$26.6M	Buy	352,400 +89,300	+34%	+$6.12M	0.03%	759
2025 Q2	$18.1M	Sell	263,100 -146,900	-36%	-$9.63M	0.02%	940
2025 Q1	$27.8M	Buy	410,000 +292,100	+248%	+$17.5M	0.03%	605
2024 Q4	$5.29M	Buy	117,900 +73,400	+165%	+$4.12M	0.01%	1461
2024 Q3	$2.8M	Sell	44,500 -31,500	-41%	-$1.84M	﹤0.01%	1626
2024 Q2	$4.49M	Buy	76,000 +57,900	+320%	+$3.62M	0.01%	1304
2024 Q1	$1.44M	Sell	18,100 -7,800	-30%	-$596K	﹤0.01%	1932
2023 Q4	$2.05M	Buy	+25,900	New	+$1.84M	﹤0.01%	1511

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Qube Research & Technologies (QRT)'s CVS Position: Q1 2026 in Review

Qube Research & Technologies (QRT) increased its CVS Health (CVS) stake by 32% in Q1 2026, buying an estimated $39.8M and bringing the position to 2,150,366 shares worth $154M. The position accounts for 0.17% of the portfolio, ranked #126.

Qube Research & Technologies (QRT) first reported a position in CVS in Q1 2018 and has held it in 25 quarters since. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

Qube Research & Technologies (QRT) held 2,150,366 shares of CVS Health worth $154M as of Q1 2026.
Qube Research & Technologies (QRT) bought 516,220 CVS Health shares in Q1 2026, an estimated $39.8M.
CVS Health made up 0.17% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #126 holding.
Qube Research & Technologies (QRT) first reported a position in CVS Health in Q1 2018 and has held it in 25 quarters since.
1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.